ESR1 and lung cancer: GPER1, a third novel estrogen receptor that binds to estrogen, has recently been found to have elevated expression in lung cancer tissue than in normal lung tissue (4), and to promote proliferation, invasion, and migration of NSCLC cells induced by E2 and its selective agonist G1 (3).